(CVLT) CommVault Systems - Overview
Stock: Data Protection, Cloud Recovery, Cyber Resilience, Backup, Disaster Recovery
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 60.7% |
| Relative Tail Risk | -16.4% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.98 |
| Alpha | -69.98 |
| Character TTM | |
|---|---|
| Beta | 1.404 |
| Beta Downside | 1.463 |
| Drawdowns 3y | |
|---|---|
| Max DD | 58.37% |
| CAGR/Max DD | 0.18 |
Description: CVLT CommVault Systems January 07, 2026
Commvault Systems, Inc. (NASDAQ:CVLT) delivers a cyber-resilience platform that secures and restores data across on-premises, cloud, and hybrid environments. Its product suite includes Operational Recovery (backup and cost-optimized cloud mobility), Autonomous Recovery (automated disaster-recovery workflows), Cyber Recovery (threat-scanning and deception), Cleanroom Recovery (isolated cloud-based test environments), HyperScale X (scale-out protection for legacy, container and virtual workloads), Cloud Air-Gap Protect (air-gapped cloud storage), Compliance reporting, Cloud Rewind (application-level restores), and Clumio Backtrack for Amazon S3 objects, complemented by professional services.
Key market signals that could affect CVLT’s growth include: (1) the global data-protection market is projected to expand at a ~12% CAGR through 2028, driven by rising ransomware incidents and regulatory pressure; (2) Commvault reported FY 2024 revenue of $1.03 billion, a 7% YoY increase, with subscription-based ARR now representing ~55% of total revenue, indicating a shift toward recurring-revenue models; and (3) the company’s gross margin has stabilized around 71%, comparable to peers such as Veeam and Rubrik, suggesting competitive pricing power. These drivers assume continued enterprise migration to multi-cloud architectures and that CVLT can maintain its integration advantage versus pure-play cloud backup vendors.
For a deeper, data-driven look at CVLT’s valuation and risk profile, you may find ValueRay’s analyst notes worth reviewing.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 87.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA -11.27 > 1.0 |
| NWC/Revenue: 72.22% < 20% (prev 6.89%; Δ 65.34% < -1%) |
| CFO/TA 0.09 > 3% & CFO 189.4m > Net Income 87.0m |
| Net Debt (-75.9m) to EBITDA (110.4m): -0.69 < 3 |
| Current Ratio: 2.34 > 1.5 & < 3 |
| Outstanding Shares: last quarter (44.6m) vs 12m ago -1.26% < -2% |
| Gross Margin: 81.44% > 18% (prev 0.82%; Δ 8062 % > 0.5%) |
| Asset Turnover: 74.92% > 50% (prev 92.20%; Δ -17.27% > 0%) |
| Interest Coverage Ratio: 40.58 > 6 (EBITDA TTM 110.4m / Interest Expense TTM 2.47m) |
Altman Z'' 0.38
| A: 0.41 (Total Current Assets 1.45b - Total Current Liabilities 616.6m) / Total Assets 2.04b |
| B: -0.62 (Retained Earnings -1.25b / Total Assets 2.04b) |
| C: 0.07 (EBIT TTM 100.1m / Avg Total Assets 1.53b) |
| D: -0.69 (Book Value of Equity -1.25b / Total Liabilities 1.82b) |
| Altman-Z'' Score: 0.38 = B |
Beneish M -3.05
| DSRI: 1.10 (Receivables 361.8m/271.4m, Revenue 1.15b/943.9m) |
| GMI: 1.01 (GM 81.44% / 81.95%) |
| AQI: 0.64 (AQ_t 0.27 / AQ_t-1 0.42) |
| SGI: 1.22 (Revenue 1.15b / 943.9m) |
| TATA: -0.05 (NI 87.0m - CFO 189.4m) / TA 2.04b) |
| Beneish M-Score: -3.05 (Cap -4..+1) = AA |
What is the price of CVLT shares?
Over the past week, the price has changed by +0.43%, over one month by -31.52%, over three months by -31.19% and over the past year by -50.12%.
Is CVLT a buy, sell or hold?
- StrongBuy: 6
- Buy: 1
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CVLT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 139.8 | 62.4% |
| Analysts Target Price | 139.8 | 62.4% |
| ValueRay Target Price | 87.6 | 1.8% |
CVLT Fundamental Data Overview February 01, 2026
P/E Forward = 17.3611
P/S = 3.2945
P/B = 17.4087
P/EG = 2.26
Revenue TTM = 1.15b USD
EBIT TTM = 100.1m USD
EBITDA TTM = 110.4m USD
Long Term Debt = 879.8m USD (from longTermDebt, last quarter)
Short Term Debt = 6.99m USD (from shortTermDebt, last quarter)
Debt = 950.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -75.9m USD (from netDebt column, last quarter)
Enterprise Value = 3.70b USD (3.78b + Debt 950.5m - CCE 1.03b)
Interest Coverage Ratio = 40.58 (Ebit TTM 100.1m / Interest Expense TTM 2.47m)
EV/FCF = 20.40x (Enterprise Value 3.70b / FCF TTM 181.5m)
FCF Yield = 4.90% (FCF TTM 181.5m / Enterprise Value 3.70b)
FCF Margin = 15.82% (FCF TTM 181.5m / Revenue TTM 1.15b)
Net Margin = 7.58% (Net Income TTM 87.0m / Revenue TTM 1.15b)
Gross Margin = 81.44% ((Revenue TTM 1.15b - Cost of Revenue TTM 212.9m) / Revenue TTM)
Gross Margin QoQ = 81.11% (prev 80.07%)
Tobins Q-Ratio = 1.82 (Enterprise Value 3.70b / Total Assets 2.04b)
Interest Expense / Debt = 0.15% (Interest Expense 1.45m / Debt 950.5m)
Taxrate = 34.20% (9.24m / 27.0m)
NOPAT = 65.9m (EBIT 100.1m * (1 - 34.20%))
Current Ratio = 2.34 (Total Current Assets 1.45b / Total Current Liabilities 616.6m)
Debt / Equity = 4.39 (Debt 950.5m / totalStockholderEquity, last quarter 216.7m)
Debt / EBITDA = -0.69 (Net Debt -75.9m / EBITDA 110.4m)
Debt / FCF = -0.42 (Net Debt -75.9m / FCF TTM 181.5m)
Total Stockholder Equity = 279.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 5.68% (Net Income 87.0m / Total Assets 2.04b)
RoE = 31.15% (Net Income TTM 87.0m / Total Stockholder Equity 279.3m)
RoCE = 8.64% (EBIT 100.1m / Capital Employed (Equity 279.3m + L.T.Debt 879.8m))
RoIC = 9.16% (NOPAT 65.9m / Invested Capital 719.0m)
WACC = 8.88% (E(3.78b)/V(4.73b) * Re(11.09%) + D(950.5m)/V(4.73b) * Rd(0.15%) * (1-Tc(0.34)))
Discount Rate = 11.09% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF Debug] Terminal Value 75.16% ; FCFF base≈191.5m ; Y1≈194.2m ; Y5≈211.6m
Fair Price DCF = 73.69 (EV 3.16b - Net Debt -75.9m = Equity 3.24b / Shares 44.0m; r=8.88% [WACC]; 5y FCF grow 1.13% → 2.90% )
EPS Correlation: 30.82 | EPS CAGR: 12.59% | SUE: 1.93 | # QB: 1
Revenue Correlation: 92.84 | Revenue CAGR: 11.89% | SUE: 3.45 | # QB: 1
EPS next Quarter (2026-06-30): EPS=1.10 | Chg30d=+0.080 | Revisions Net=-1 | Analysts=12
EPS next Year (2027-03-31): EPS=4.82 | Chg30d=+0.288 | Revisions Net=-1 | Growth EPS=+15.1% | Growth Revenue=+11.4%